首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1542926

全球皮肤镜设备市场 - 2024-2031

Global Dermatoscope Devices Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

2023年，全球皮肤镜设备市场达到9.7129亿美元，预计到2031年将达到19.3089亿美元，2024-2031年预测期间复合年增长率为9.2%。

皮肤镜设备是用于详细检查皮肤的专用医疗仪器。它们提供皮肤病变、痣和其他皮肤异常的放大视图，从而更好地可视化肉眼可能不可见的表面和地下结构。皮肤镜的主要目的是帮助早期发现、诊断和监测各种皮肤状况，包括皮肤癌、良性病变、发炎性皮肤病和感染性疾病。

皮肤镜设备通常由放大镜系统组成，通常带有偏振或非偏振光源，这有助于减少眩光并增强皮肤结构的可见度。一些皮镜还具有数位成像功能，可以捕获和储存高解析度影像，用于记录、分析和远端咨询目的。这些设备有多种形式，包括用于便携式使用的手持式型号和用于更全面检查的桌上型型号。它们在提高诊断准确性、指导活检决策和监测治疗反应方面发挥着至关重要的作用。

市场动态：

司机

皮镜设备不断进步

皮镜设备的不断进步预计将在预测期内推动市场发展。先进的皮肤镜设备结合了偏振和非偏振光源、交叉偏振和可调节放大倍率等功能，可以更好地可视化和表征皮肤病变。这提高了诊断准确性，特别是在区分良性和恶性病变方面。

此外，一些先进的皮肤镜设备利用人工智慧 (AI) 演算法进行自动病变分析和决策支援。人工智慧支援的功能有助于病变分类、风险分层和治疗建议，补充医疗保健提供者的专业知识，并有可能改善诊断结果。

例如，2024 年 1 月 17 日，私人设备製造商 DermaSensor 的使用人工智慧检测皮肤癌的手持设备获得了美国食品和药物管理局的批准。这家总部位于迈阿密的私人公司的设备也称为 DermaSensor，利用光和人工智慧驱动的演算法来帮助初级保健医生识别可疑痣或病变中是否存在癌症。

许多现代皮镜设备都配备了数位成像功能，可实现高解析度影像撷取和储存。与电子健康记录和远距医疗平台的整合有助于无缝记录、分析和远端咨询，从而提高工作流程效率和患者护理。

此外，各种皮肤癌和皮肤病的盛行率不断增加、FDA 对新型设备的批准不断增加、人们对皮肤镜设备的认识不断提高以及开发更多皮肤镜设备的技术进步，预计将在预测期内推动市场发展。

限制

对替代方法的偏好、与皮镜设备相关的高成本、监管挑战、对皮镜设备的认识有限以及与这些设备相关的技术挑战等因素预计会阻碍市场。

Market Overview

The Global Dermatoscope Devices Market reached US$ 971.29 million in 2023 and is expected to reach US$ 1,930.89 million by 2031, growing at a CAGR of 9.2% during the forecast period 2024-2031.

Dermatoscope devices are specialized medical instruments used to examine the skin in detail. They provide magnified views of skin lesions, moles and other skin abnormalities, enabling better visualization of surface and subsurface structures that may not be visible to the naked eye. The primary purpose of dermatoscopes is to aid in the early detection, diagnosis and monitoring of various skin conditions, including skin cancer, as well as benign lesions, inflammatory skin diseases and infectious conditions.

Dermatoscope devices typically consist of a magnifying lens system, often with polarized or non-polarized light sources, which help to reduce glare and enhance the visibility of skin structures. Some dermatoscopes also incorporate digital imaging capabilities, allowing for the capture and storage of high-resolution images for documentation, analysis and remote consultation purposes. These devices come in various forms, including handheld models for portable use and desktop models for more comprehensive examinations. They play a crucial role in improving diagnostic accuracy, guiding biopsy decisions and monitoring treatment responses.

Market Dynamics: Drivers

Rising advancements in dermatoscope devices

The rising advancements in dermatoscope devices are expected to drive the market over the forecast period. Advanced dermatoscope devices incorporate features such as polarized and non-polarized light sources, cross-polarization and adjustable magnification levels, allowing for better visualization and characterization of skin lesions. This leads to increased diagnostic accuracy, particularly in distinguishing between benign and malignant lesions.

Additionally, some advanced dermatoscope devices leverage artificial intelligence (AI) algorithms for automated lesion analysis and decision support. AI-powered features aid in lesion classification, risk stratification and treatment recommendations, complementing the expertise of healthcare providers and potentially improving diagnostic outcomes.

For instance, on January 17, 2024, Privately-held device maker DermaSensor cleared the U.S. Food and Drug Administration approvals for its hand-held device that uses artificial intelligence to detect skin cancer. The Miami-based private company's device - also called DermaSensor - utilizes light and an AI-powered algorithm to help primary care physicians in identifying the presence of cancer in suspicious moles or lesions.

Many modern dermatoscope devices are equipped with digital imaging capabilities, enabling high-resolution image capture and storage. Integration with electronic health records and telemedicine platforms facilitates seamless documentation, analysis and remote consultation, enhancing workflow efficiency and patient care.

Further, the increasing prevalence of various skin cancers and skin diseases, rising FDA approvals for novel devices, increasing awareness about dermatoscope devices and increasing technological advancements in the development of more dermatoscope devices are the factors expected to drive the market over the forecast period.

Restraints

Factors such as the preference for alternative methods, high cost associated with dermatoscope devices, regulatory challenges, limited awareness about dermatoscope devices and technical challenges associated with these devices are the factors expected to hamper the market.

Segment Analysis

The global dermatoscope devices market is segmented based on product type, modality, application, end-user and region.

The digital dermatoscope segment accounted for approximately 39.4% of the dermatoscope devices market share

The digital dermatoscope segment is expected to hold the largest market share over the forecast period. Digital dermatoscopes capture high-resolution images of skin lesions, providing detailed and accurate visual documentation. These images can be magnified, manipulated and stored for further analysis, making them invaluable for monitoring lesion changes over time and facilitating remote consultations.

For instance, on June 6, 2023, DeepX Diagnostics received clearance from the US Food and Drug Administration (FDA) for its digital dermatoscope DermoSight for teledermatology screening of suspect skin cancer lesions in the United States. DermoSight is currently cleared to acquire skin lesion images for teledermatology assessment, like existing digital dermatoscopes. It is also designed for integration with an AI algorithm, empowered by proprietary optical transfer diagnosis (OTD) technology, although the FDA has yet to approve the commercial use of the OTD technology with DermoSight. OTD enables the analysis of lesions on the sub-skin level based on their light-transferring properties. The technology is designed to turn dermatoscopic assessment into a robust, non-invasive and accessible AI-driven tool and to streamline and fast-track skin cancer diagnosis.

Digital dermatoscopes often incorporate advanced features such as polarized or non-polarized light, adjustable magnification and image enhancement algorithms, which enhance the visualization of surface and subsurface structures of the skin. This allows for better characterization of lesions and improves diagnostic accuracy. These devices also enables patients to actively participate in their care by allowing them to view and discuss their skin images with healthcare providers.

Geographical Analysis

North America accounted for approximately 41.3% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and rising demand for dermatoscope devices. North America especially the United States is known hub for its strong presence of major players such as medical device companies. This presence of major players in the region aims to develop more technologically advanced dermatoscope devices through digital features and AI algorithms.

In addition, there is an increasing demand for dermatoscope devices due to the increasing prevalence of skin cancers in the region especially in the United States. For instance, according to the American Academy of Dermatology Association, skin cancer is the most common cancer in the United States. Current estimates are that one in five Americans will develop skin cancer in their lifetime. It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. Research estimates that nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), affects more than 3 million Americans a year. More than 1 million Americans are living with melanoma.

Competitive Landscape

The major global players in the dermatoscope devices market include HEINE Optotechnik GmbH & Co. KG, Optilia Medical, FotoFinder Systems GmbH, Rudolf Riester GmbH, Canfield Scientific, Inc., Firefly Global, Illuco Co., Ltd., DermLite, HILLROM & WELCH ALLYN and KRUPA MEDI SCAN among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global dermatoscope devices market. The COVID-19 pandemic has caused a massive shift towards telehealth, including teledermatology and teledermoscopy, making these devices more relevant. There have been several studies evaluating patient-directed dermoscopy during a self-skin examination. Some patients postponed seeking medical attention for skin concerns during the pandemic, either due to fear of contracting the virus or logistical challenges associated with accessing healthcare services. As a result, there may have been delays in the diagnosis and treatment of skin conditions, including skin cancer, which could impact the demand for dermatoscope devices in the short term.

Why Purchase the Report?

To visualize the global dermatoscope devices market segmentation based on product type, modality, application, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of dermatoscope devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global dermatoscope devices market report would provide approximately 69 tables, 72 figures, and 187 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Advancements in Dermatoscope Devices
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of the Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Digital Dermatoscope*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hybrid Dermatoscope
7.4. Contact Dermatoscope
7.5. Noncontact Dermatoscope

8. By Modality

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 8.1.2. Market Attractiveness Index, By Modality
8.2. Handheld Dermatoscopes*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Desktop Dermatoscopes

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Skin Disease Diagnosis*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Examination of Skin Lesions
9.4. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Dermatology Centers
10.5. Diagnostic Centers
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. HEINE Optotechnik GmbH & Co. KG*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Optilia Medical
13.3. FotoFinder Systems GmbH
13.4. Rudolf Riester GmbH
13.5. Canfield Scientific, Inc.
13.6. Firefly Global
13.7. Illuco Co., Ltd.
13.8. DermLite
13.9. HILLROM & WELCH ALLYN
13.10. KRUPA MEDI SCAN (LIST NOT EXHAUSTIVE)